Goldman Sachs’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-41,000
Closed -$868K 6368
2024
Q4
$868K Buy
41,000
+19,000
+86% +$499K ﹤0.01% 4911
2024
Q3
$709K Buy
+22,000
New +$650K ﹤0.01% 4857

Other funds holding SGRY

Goldman Sachs's SGRY Position: Q2 2026 in Review

Goldman Sachs reduced its Surgery Partners (SGRY) stake by 16% in Q2 2026, selling an estimated $2.82M and leaving 1,079,626 shares worth $18.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2738.

Goldman Sachs first reported a position in SGRY in Q4 2015 and has held it in 38 quarters since. The position peaked at $43M in Q2 2023. 188 funds tracked by Wall St. Rank hold SGRY as of Q2 2026.

  • Goldman Sachs held 1,079,626 shares of Surgery Partners worth $18.1M as of Q2 2026.
  • Goldman Sachs sold 200,926 Surgery Partners shares in Q2 2026, an estimated $2.82M.
  • Surgery Partners made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #2738 holding.
  • Goldman Sachs first reported a position in Surgery Partners in Q4 2015 and has held it in 38 quarters since.
  • Goldman Sachs's Surgery Partners position peaked at $43M in Q2 2023.
  • 188 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.